16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Issues in treatment-resistant depression.

      The Journal of clinical psychiatry
      Anticonvulsants, therapeutic use, Antidepressive Agents, Controlled Clinical Trials as Topic, standards, statistics & numerical data, Cost of Illness, Depressive Disorder, Major, drug therapy, epidemiology, therapy, Drug Resistance, Drug Therapy, Combination, Electroconvulsive Therapy, Humans, Lithium Compounds, Prevalence, Psychotherapy, Terminology as Topic, Treatment Outcome

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Major depressive disorder is a debilitating disease that imposes significant social and economic burdens not only on patients but also on society. Although various treatment options are available, treatment-resistant depression is common. Determining the exact prevalence of treatment-resistant depression is difficult because definitions vary, as do definitions of antidepressant response. Operational definitions of antidepressant response, nonresponse, partial response, and remission will be discussed in this article. Pharmacotherapy options for patients with treatment-resistant depression include augmentation, combination, and switching therapies; however, data from controlled clinical trials supporting these therapies are limited. Electroconvulsive therapy and psychotherapy offer additional treatment strategies. New nonpharmacologic therapies are under investigation. Remission is the goal of treatment.

          Related collections

          Author and article information

          Comments

          Comment on this article